Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Asthma-I: Introduction

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...

Asthma-III: Symptoms and Complications

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma

Asthma-II: Pathophysiology and Classification

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:

Asthma: Pathogenesis and Management

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation

Asthma-IV: Diagnostic and Management

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Vancomycin exposure in critically ill children undergoing high intensity continuous renal replacement therapy.

Pediatric nephrology (Berlin, Germany)·2026

Same author

Readmission and Late Mortality Among Children With Congenital Diaphragmatic Hernia.

JAMA network open·2026

Same author

A three-year randomized, double-blind, placebo-controlled study of lanreotide in stage 2/3 autosomal dominant polycystic kidney disease.

Kidney international·2026

Same author

Piperacillin Population Pharmacokinetics in Plasma and Peritoneal Fluid and Dosing Optimization in Children Undergoing Liver Transplant: An Optimome Study.

Clinical pharmacology and therapeutics·2026

Same author

Pregnancy-related effect on elexacaftor, tezacaftor and ivacaftor pharmacokinetics in women with cystic fibrosis.

British journal of clinical pharmacology·2026

Same author

Physiologically Based Pharmacokinetic Modeling of Elexacaftor/Tezacaftor/Ivacaftor in Infants With Cystic Fibrosis.

CPT: pharmacometrics & systems pharmacology·2026

Search research articles

Related Experiment Video

Updated: Feb 16, 2026

Measuring Carbon Content in Airway Macrophages Exposed to Carbon-Containing Particulate Matters

Measuring Carbon Content in Airway Macrophages Exposed to Carbon-Containing Particulate Matters

Published on: July 12, 2024

Fine particulate pollution and asthma exacerbations.

Naïm Bouazza^1,2, Frantz Foissac^1,2, Saik Urien^1,2

¹Pharmacology and Clinical Research Departments, Paris Descartes Necker Cochin, Assistance Publique - Hopitaux de Paris, Paris, France.

Archives of Disease in Childhood

|December 21, 2017

Summary

Fine particulate matter (PM2.5) exposure is linked to increased childhood asthma exacerbations, particularly in urban environments. This study highlights the non-linear relationship between PM2.5 and emergency department visits for pediatric asthma.

Keywords:

general paediatrics

More Related Videos

Aggravation of Myocardial Ischemia upon Particulate Matter Exposure in Atherosclerosis Animal Model

Aggravation of Myocardial Ischemia upon Particulate Matter Exposure in Atherosclerosis Animal Model

Published on: December 10, 2021

Flow Cytometric Analysis of Particle-bound Bet v 1 Allergen in PM10

Flow Cytometric Analysis of Particle-bound Bet v 1 Allergen in PM10

Published on: November 19, 2016

Related Experiment Videos

Last Updated: Feb 16, 2026

Measuring Carbon Content in Airway Macrophages Exposed to Carbon-Containing Particulate Matters

Measuring Carbon Content in Airway Macrophages Exposed to Carbon-Containing Particulate Matters

Published on: July 12, 2024

Aggravation of Myocardial Ischemia upon Particulate Matter Exposure in Atherosclerosis Animal Model

Aggravation of Myocardial Ischemia upon Particulate Matter Exposure in Atherosclerosis Animal Model

Published on: December 10, 2021

Flow Cytometric Analysis of Particle-bound Bet v 1 Allergen in PM10

Flow Cytometric Analysis of Particle-bound Bet v 1 Allergen in PM10

Published on: November 19, 2016

Area of Science:

Environmental Health
Pediatric Pulmonology
Epidemiology

Background:

Epidemiological studies on outdoor air pollution and childhood asthma show mixed results.
Understanding the specific impact of air pollutants on pediatric asthma exacerbations is crucial for public health.

Purpose of the Study:

To investigate the association between exposure to air pollutants and asthma exacerbation in children.
To analyze the relationship between fine particulate matter and emergency department visits for pediatric asthma.

Main Methods:

Utilized a large database of over 1.2 million pediatric emergency department visits from 2010-2015.
Collected hourly/daily data on air pollutants (PM2.5, PM10, NO2, O3), meteorological factors, RSV, and pollen.
Employed mixed-effects quasi-Poisson regression modeling to assess air pollution's impact on asthma exacerbations.

Main Results:

Fine particulate matter (PM2.5) was the only pollutant independently associated with emergency department visits for asthma.
The relationship between PM2.5 exposure and asthma exacerbation was non-linear, best described by a sigmoid function.
The estimated PM2.5 concentration for half the maximum effect was 13.5 µg/m³.

Conclusions:

A significant association exists between daily asthma exacerbations in pediatric emergency department visits and exposure to fine particulate air pollutants.
PM2.5 is a key environmental factor contributing to childhood asthma exacerbations.
The findings underscore the need for air quality interventions to mitigate pediatric asthma burden.